Nicholas Investment Partners, LP - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 185 filers reported holding SAGE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nicholas Investment Partners, LP ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$6,465,000
-22.9%
105,771
+77.0%
0.70%
-0.9%
Q3 2019$8,384,000
-41.0%
59,761
-23.0%
0.70%
-45.9%
Q2 2019$14,211,000
+11.4%
77,616
-3.2%
1.30%
+14.7%
Q1 2019$12,752,000
+149.5%
80,178
+50.3%
1.14%
+106.7%
Q4 2018$5,112,000
-54.3%
53,363
-32.6%
0.55%
-38.7%
Q3 2018$11,184,000
-11.8%
79,176
-2.2%
0.90%
+0.7%
Q2 2018$12,678,000
+27.1%
80,994
+30.7%
0.89%
+24.8%
Q1 2018$9,978,000
-22.4%
61,946
-20.7%
0.71%
+68.0%
Q4 2017$12,864,000
+389.7%
78,104
+85.2%
0.42%
+133.5%
Q3 2017$2,627,000
-56.5%
42,173
-44.4%
0.18%
-57.3%
Q2 2017$6,036,000
+11.6%
75,805
-0.3%
0.43%
+11.8%
Q1 2017$5,408,000
+21.6%
76,059
-12.7%
0.38%
+13.1%
Q4 2016$4,448,000
+35.1%
87,159
+21.9%
0.34%
+53.9%
Q3 2016$3,292,000
+75.3%
71,483
+22.0%
0.22%
+59.9%
Q1 2016$1,878,000
-47.9%
58,580
-5.2%
0.14%
-45.0%
Q4 2015$3,602,000
+23.1%
61,789
-10.6%
0.25%
+18.6%
Q3 2015$2,925,000
-29.4%
69,127
+21.8%
0.21%
-20.8%
Q2 2015$4,143,000
+46.7%
56,752
+0.9%
0.26%
+49.7%
Q1 2015$2,825,000
+18.4%
56,246
-13.7%
0.18%
+18.8%
Q4 2014$2,386,000
+18.0%
65,186
+1.6%
0.15%
+18.3%
Q3 2014$2,022,00064,1850.13%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders